PMID: 6989377Jan 1, 1980Paper

Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol

B VessbyJ Boberg


The fatty acid composition of the plasma lipid esters has been studied during lipid-lowering treatment of 95 patients with atherosclerotic disease. During the first two months of the trial only a diet was prescribed. During the ensuing two months either clofibrate or niceritrol, a nicotinic acid ester, was added in a randomized order. During the last two months the second drug was added. The combined treatment with diet, clofibrate and niceritrol caused highly significant serum lipid reductions. The fatty acid composition in the plasma lipid esters was determined in samples from each trial period to measure the degree of dietary adherence. During dietary treatment the relative content of saturated and monounsaturated fatty acids secreased and the polyunsaturated fatty acids increased with an increasing ratio between pulyunsaturated and saturated fatty acids (P/S ratio) in the cholesterol esters and triglycerides. Only minor changes were seen in the phospholipids. The changes caused by the diet were partly reversed by clofibrate while niceritrol did not cause any major changes of the fatty acid composition. Clofibrate treatment coincided with increasing amounts of monounsaturated fatty acids, especially oleate (18 : 1), in the c...Continue Reading


Oct 24, 1975·Science·R J DeckelbaumP K George
Apr 1, 1978·Circulation Research·R L JacksonA M Gotto
Jan 1, 1970·Atherosclerosis·J JURAND, M F OLIVER
Sep 1, 1966·Clinica Chimica Acta; International Journal of Clinical Chemistry·J Boberg
Jan 10, 1974·The New England Journal of Medicine·R L Jackson, A M Gotto
Jan 12, 1967·The New England Journal of Medicine·D S FredricksonR S Lees
Jan 26, 1967·The New England Journal of Medicine·D S FredricksonR S Lees
Feb 2, 1967·The New England Journal of Medicine·D S FredricksonR S Lees
Jan 19, 1967·The New England Journal of Medicine·D S FredricksonR S Lees
May 11, 1957·Lancet·E H AHRENSM L PETERSON
Sep 1, 1963·Journal of Atherosclerosis Research·C BERRYJ D NABARRO


Aug 25, 1989·Pharmaceutisch Weekblad. Scientific Edition·J J van DoormaalH Doorenbos
Jan 13, 2006·Current Opinion in Lipidology·Ana Baylin, Hannia Campos
Oct 1, 1991·British Journal of Clinical Pharmacology·N Agheli, B Jacotot
Dec 13, 1982·Biochimica Et Biophysica Acta·Y Kawashima, H Kozuka
Oct 1, 1992·Scandinavian Journal of Clinical and Laboratory Investigation·G Wahlberg, G Walldius
Feb 1, 1993·Prostaglandins, Leukotrienes, and Essential Fatty Acids·C Y HongM S Shiao
Sep 12, 2006·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Allison M HodgeGraham G Giles
Nov 1, 1983·Atherosclerosis·T NikkariA Aromaa
Jan 1, 1981·Acta Medica Scandinavica·H LithellB Hood

Related Concepts

Cholesterol Esters
Clinical Trials
Diet Therapy
Dose-Response Relationship, Drug
Saturated Fat
Linoleic Acids
Myocardial Infarction
Nicotinic Acids

Related Feeds

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.